Mycoplasma synoviaein the guinea‐fowl

Clinical expression, epidemiology and monitoring of Mycoplasma gallisepticum and Mycoplasma synoviae: an update

Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) are of clinical and economic importance for the global poultry industry. Many countries and integrations are involved in monitoring programs to control both mycoplasma species. This review provides an extensive historic overview of the last seven decades on the development of the knowledge regarding the factors that influence the clinical expression of the disease, the epidemiology and monitoring of both MG and MS. This includes the detection of new virulent strains, studies unravelling the transmission routes, survival characteristics and the role of other avian hosts. Also the role of molecular typing tests in unravelling epidemiology, and factors that complicate the interpretation of test results such as heterologous mycoplasma infections, use of heterologous oil-emulsion vaccines, use of antibiotic treatments, occurrence of MG and MS strains with low virulence, and last but not least the use of live and/or inactivated MG and MS vaccines are discussed.

Epidemiological investigation of Mycoplasma Synoviae in native chicken breeds in China

Backgroud

Mycoplasma synoviae (M. synoviae) is widely distributed around the world, and leads to serious economic losses in the world every year. Nevertheless, the incidence and epidemiology of M. synoviae infection in China have remained unclear.

Results

In this study we demonstrate that over 9773 broiler chicken flocks in 16 Chinese provinces were affected by M. synoviae between 2010 and 2015. Our epidemiological study revealed that M. synoviae was widely prevalent in multi-aged Chinese native breeder chickens, and the prevalence of M. synoviae in embryos of breeders reached up to 16.29%. In addition, our data showed that chickens aged 14 days or younger carried simultaneously high levels of maternal antibody against M. synoviae and high M. synoviae infection (10%), and low M. synoviae antibody levels in breeders and high proportion of M. synoviae infection in embryos could increase the chances of incidence in the offspring. Finally, our results also indicated that 3- to 7-week-old chickens might be most the susceptible to M. synoviae and, therefore, might play a key role in the horizontal transmission of M. synoviae.

Conclusion

Our findings suggest that M. synoviae is widely circulating in Chinese native chickens, accordingly, effective control measures are urgently needed to control the spread.

Isolation of Mycoplasma synoviae from the red-legged partridge (Alectoris rufa)

Following an outbreak of respiratory disease in a group of red-legged partridges (Alectoris rufa) and chickens (Gallus domesticus) housed in the same unit, a mycoplasma was isolated. Its biochemical profile and the growth-inhibition test enabled it to be identified as Mycoplasma synoviae. Histopathological analysis revealed an intense inflammatory reaction in the respiratory tract, together with epithelial hyperplasia and lymphocyte infiltration. The rapid serum plate agglutination test, and the haemagglutination-inhibition test, revealed the presence of humoral antibodies to Mycoplasma synoviae in the partridges studied.

Detection of Mycoplasma synoviae in clinically normal pheasants

Mycoplasma synoviae was isolated from the tracheas of seven clinically normal pheasants found in the vicinity of a chicken farm infected with M synoviae, but not from 120 pheasants and partridges with respiratory disease. When specimens were examined by the polymerase chain reaction only two additional pheasants infected with M synoviae were identified, one healthy and one diseased.

Respiratory diseases of gallinaceous birds

Respiratory conditions constitute many of the diseases affecting all avian species, including gallinaceous birds. Clinical signs and gross lesions of different respiratory diseases are often similar, and establishing a definitive diagnosis may require ancillary laboratory testing. Determination of a specific diagnosis allows practitioners to select the most effective therapies and to prescribe a management program that prevents recurrence.